Soleno Therapeutics (SLNO) Inventory (2014 - 2026)
Soleno Therapeutics (SLNO) reported Inventory of $17.3 million for Q1 2026, up 15.2% on a QoQ basis from $15.0 million in Q4 2025.
Soleno Therapeutics (SLNO) has 6 years of Inventory data on file, last reported at $17.3 million in Q1 2026.
- Quarterly Inventory changed N/A year-over-year to $17.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.3 million (changed N/A YoY) and the FY2025 annual result came in at $15.0 million, changed N/A from the prior year.
- Inventory climbed to $17.3 million in Q1 2026 per SLNO's latest filing, from $15.0 million in the prior quarter.
- Across five years, Inventory topped out at $17.3 million in Q1 2026 and bottomed at $2.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 17.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.31 Mn |
| Dec 31, 2025 | 15.02 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 2.36 Mn |
| Jun 30, 2017 | 164,000.00 |
| Mar 31, 2017 | 855,000.00 |
| Sep 30, 2016 | 703,000.00 |
| Jun 30, 2016 | 774,000.00 |
| Mar 31, 2016 | 653,000.00 |
| Dec 31, 2015 | 551,008.00 |
| Sep 30, 2015 | 376,000.00 |
| Jun 30, 2015 | 277,000.00 |
| Mar 31, 2015 | 206,000.00 |
| Dec 31, 2014 | 109,336.00 |